Over 110 million doses of this to about 60 countries will be met through the AstraZeneca (AZ)-Serum Institute of India partnership

New Zealand expects its nationwide rollout covering the country's population of 5 million will take a full year, while Australia aims to inoculate its 25 million citizens by October

Prior to widespread circulation of the more contagious variant, the vaccine was showing efficacy of around 75%, researchers said

Fact sheets for recipients of Moderna and Pfizer-BioNTech vaccines in US and UK clarify that the vaccines are yet to be fully approved; recipients have been asked to get help if they experience severe side effects or allergic reactions

Scientists say the new South African variant has multiple mutations in the important \"spike\" protein that the virus uses to infect human cells

Brian Pinker is among the first to be vaccinated by the Oxford University Hospital's (OUH) chief nurse, hailed as a major milestone in the phased vaccination programme being undertaken by the NHS

Moncef Slaoui, head of Operation Warp Speed, the federal vaccine program, said on CBS' \"Face the Nation\" that officials were in talks with Moderna and the Food and Drug Administration about the idea

While AstraZeneca says it expects 2 million doses of the Oxford University vaccine to be ready each week in just over a fortnight, Pfizer BioNTech said the number of doses it has now sent to the UK is 'in the millions'

Covishield DCGI approval: Pune-based Serum Institute will have to provide safety, efficacy and immunogenicity data from the ongoing clinical trials in India and globally

CDSCO's expert panel has recommended the Serum Institute of India's Covishield COVID-19 vaccine for emergency use authorisation to DCGI

Suffering poor financial health, Central government has not given a concrete answer on who will bear the cost of vaccinating Indians - Centre, states, or the people themselves

Serum Institute of India (SII) has made a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine. The SII has already manufactured 40 million doses of the vaccine

Brazil is the first country to complete a late-stage trial of the vaccine, called CoronaVac, but a release of the results, first set for early December, has now been delayed three times

World's biggest vaccine maker has already manufactured over 50 million doses; further production will start as soon as it gets necessary approvals in India and the UK. SII is hoping to supply 3 billion doses of vaccine in 2021

Authorisation by the MHRA will also give confidence to countries across the world. India has already manufactured more than 50 million of the AstraZeneca vaccines, the newspaper notes

The shots for Sputnik V are available for free for those in medical and educational facilities, whether owned by the state or privately. Social and municipal workers, retail and service workers, and those in the arts can also get the shots at no cost

A senior official from WHO told Reuters about its talks with both companies to include their coronavirus vaccines as part of an early global rollout

The deal comes in a week that AstraZeneca said it was conducting further research to confirm whether its COVID-19 vaccine could be 90% effective, potentially slowing its rollout, and as a rival shot from Pfizer was launched in Britain and approved for use in the United States

GSK said phase 1/2 interim results showed an immune response comparable to patients who recovered from COVID-19 in adults aged 18 to 49 years but there was an insufficient response in older adults

India Stock Market Highlights Today: Intraday, both indices touched all time highs today, with Sensex hitting 46,164 and Nifty touching 13,548.